Ellipsis Health · Series A

Uses patented vocal biomarker technology to assess mental and behavioral health from the sound

Amount

$45M

Round

Series A

Valuation

—

Announced

—

Investors

Lead investor

Salesforce Ventures

Participating investors

Khosla Ventures AME Cloud Ventures CVS Health Ventures Mitsui Global Investment